London (AFP) Sept 14, 2009
British drugs giant GlaxoSmithKline said on Monday that trials had shown one dose of its swine flu vaccine produced "a strong immune response".
"The results demonstrate that after one dose the candidate vaccine can provide a strong immune response," GSK said in a statement.
The trial, which is taking place in Germany, involves 130 healthy volunteers aged 18 to 60.
Chinese biotech company Sinovac has already obtained the green light from Chinese authorities to produce a one-dose vaccine.
And French firm Sanofi-Pasteur and CSL of Australia said last week that tests had shown vaccines they had developed were also effective in a single dose.
Share This Article With Planet Earth
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
One shot enough against swine flu, US studies confirm
Washington (AFP) Sept 11, 2009
A single dose of vaccine could be enough to immunize adults against swine flu, a top US health official said Friday, allaying fears of a scramble for a tight supply of shots when flu season returns. "Preliminary data from our trials indicate that a single 15-microgram dose of ... vaccine is well tolerated and induces an immune response in most healthy adults," said Anthony Fauci, director of ... read more
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2009 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement|